Pursuant to Regulation 34 of the SEBI ((Listing Obligations and Disclosure Requirements) Regulations, 2015, Suven Pharmaceuticals has informed that it enclosed the Notice convening the 4th AGM of the Members of the Company and the Annual Report for the fiscal 2022 which is simultaneously circulated to the shareholders through electronic mode. The 4th AGM will be held on Thursday, August 18, 2022 at 11:30 am IST through Video Conference (VC)/ Other Audio-Visual Means (OAVM). The Notice and Annual Report will also be hosted on the Company’s website. The schedule of the AGM is enclosed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1695.00 |
| Dr. Reddys Lab | 1223.95 |
| Cipla | 1240.50 |
| Zydus Lifesciences | 944.65 |
| Lupin | 2333.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: